NAOSITE : Nagasaki University's Academic Output SITE >
130 病院 >
130 学術雑誌論文 >
Sodium pentosan polysulfate resulted in cartilage improvement in knee osteoarthritis--an open clinical trial.
|タイトル: ||Sodium pentosan polysulfate resulted in cartilage improvement in knee osteoarthritis--an open clinical trial.|
|著者: ||Kumagai, Kenji / Shirabe, Susumu / Miyata, Noriaki / Murata, Masakazu / Yamauchi, Atsushi / Kataoka, Yasuhumi / Niwa, Masami|
|発行日: ||2010年 3月28日|
|出版者: ||BioMed Central Ltd.|
|引用: ||BMC clinical pharmacology, 10, article no.7; 2010|
|抄録: ||BACKGROUND: Pentosan polysulfate sodium (pentosan) is a semi-synthetic drug manufactured from beech-wood hemicellulose by sulfate esterification of the xylopyranose hydroxyl groups. From in vitro and animal model studies, pentosan has been proposed as a disease modifying osteoarthritis drug (DMOAD). The objective of this study was to assess the efficacy, safety, and patient satisfaction in patients with mild radiographic knee osteoarthritis (OA) findings and OA-associated symptoms and signs. METHODS: Twenty patients were assessed clinically at Nagasaki University Hospital. The radiographic indications of OA were grade 1 to 3 using the Kellgren-Lawrence Grading System (K/L grade). Pentosan used in this study was manufactured and supplied in sterile injectable vials (100 mg/ml) by bene GmbH, Munich, Germany. The study was a single-center, open-label trial. Treatment consisted of 6 weekly subcutaneous injections (sc) of pentosan (2 mg/kg). Patients were clinically assessed at entry and 1 to 8, 11, 15, 24 & 52 weeks post treatment. The results were analyzed using one way ANOVA and Dunnett's method. RESULTS: Hydrarthroses were reduced quickly in all cases. The clinical assessments, i.e., knee flexion, pain while walking, pain after climbing up and down stairs, etc, were improved significantly and these clinical improvements continued for almost one year. The dose used in this study affected the blood coagulation test, but was within safe levels. Slightly abnormal findings were noted in serum triglycerides. CONCLUSIONS: Pentosan treatment in twenty patients with mild knee OA seemed to provide improvements in clinical assessments and C2C level of cartilage metabolism.|
|PubMed ID: ||20346179|
|権利: ||© 2010 Kumagai et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.|
|資料タイプ: ||Journal Article|